Cargando…
Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells
In the last 30 years, the 5-year-survival rate of patients with osteosarcoma has not improved as a result of the low prevalence and large tumor heterogeneity. Therefore, the development of novel drugs for the treatment of osteosarcoma is urgently required. The present study aimed to identify potenti...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626196/ https://www.ncbi.nlm.nih.gov/pubmed/26398440 http://dx.doi.org/10.3892/mmr.2015.4338 |